BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 6602233)

  • 1. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
    Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
    Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
    Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
    Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of aging on complement activity (CH50) and complement protein levels.
    Nagaki K; Hiramatsu S; Inai S; Sasaki A
    J Clin Lab Immunol; 1980 Jan; 3(1):45-50. PubMed ID: 7381926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immune complex and complement levels in spontaneous abortions and normal pregnancy].
    Saitoh S; Nakanishi A; Ichijo M
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Nov; 35(11):1981-90. PubMed ID: 6607297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune complexes in schistosomiasis IV. C3, C4 and C1q characterization and correlation between C3 in serum and circulating IC levels.
    Santoro F; Bout D; Camus D; Capron A
    Rev Inst Med Trop Sao Paulo; 1977; 19(1):39-42. PubMed ID: 897474
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes of serum complement concentrations in tumour patients prior and after radiotherapy.
    Beyer-Enke SA; Strauss LG; Georgi M
    Strahlenther Onkol; 1986 Jul; 162(7):441-7. PubMed ID: 3488595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating immune complexes and complement levels in hemophilic children.
    Verroust F; Adam C; Kourilsky O; Allain JP; Verroust P
    J Clin Lab Immunol; 1981 Sep; 6(2):127-30. PubMed ID: 6912882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement levels in cigarette smokers: elevation of serum concentrations of C5, C9, and C1-inhibitor.
    Wyatt RJ; Bridges RB; Halatek DG
    J Clin Lab Immunol; 1981 Sep; 6(2):131-5. PubMed ID: 7288869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune complexes in solid tumours precipitable by 3.5% polyethylene glycol: analysis of some nonspecific components.
    Guidi L; Baroni R; Bartoloni C; Pellegrino M; Tricerri A; Marciano M; Barone C; Gambassi G
    Diagn Clin Immunol; 1988; 5(6):284-8. PubMed ID: 3219777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune complexes in diabetes mellitus: studies of complement utilisation and tissue deposition.
    Charlesworth JA; Campbell LV; Catanzaro R; Pussell BA; Pasterfield GV; Peake P
    J Clin Lab Immunol; 1982 Sep; 8(3):163-8. PubMed ID: 6752415
    [No Abstract]   [Full Text] [Related]  

  • 12. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activation in fetuses: assessment by the levels of complement components and split products in cord blood.
    Miyano A; Nakayama M; Fujita T; Kitajima H; Imai S; Shimizu A
    Diagn Clin Immunol; 1987; 5(2):86-90. PubMed ID: 3497734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and molecular genetics of complement proteins. An update.
    Volanakis JE
    Year Immunol; 1986; 2():164-76. PubMed ID: 3554821
    [No Abstract]   [Full Text] [Related]  

  • 15. [Protein chemistry of the complement system].
    Nagasawa S
    Tanpakushitsu Kakusan Koso; 1983 Jan; 28(1):18-44. PubMed ID: 6340167
    [No Abstract]   [Full Text] [Related]  

  • 16. Complement factors and acute phase reactants in the Guillain-Barré syndrome.
    Tönnessen TI; Nyland H; Aarli JA
    Eur Neurol; 1982; 21(2):124-8. PubMed ID: 6920298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hereditary complement deficiencies].
    Fischer E
    Hautarzt; 1982 Feb; 33(2):65-72. PubMed ID: 6281215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hereditary angioedema: description of a sibship and review].
    Matter L; Schopfer K; Voegelin HP; Fueter R
    Schweiz Med Wochenschr; 1981 Aug; 111(34):1238-45. PubMed ID: 6974398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
    Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complement activation after the intravascular administration of contrast media: a comparison between ionic and nonionic x-ray contrast media].
    Hoffmeister HM; Fuhrer G; Platten HP; Heller W
    Rofo; 1987 Dec; 147(6):673-5. PubMed ID: 2827265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.